| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |